We learn most when we have benchmarking and we can examine our own processes of care, explained Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
We learn most when we have benchmarking and we can examine our own processes of care, explained Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Transcript
What are some best strategies for practices to succeed in the evolving cancer landscape?
I wish I knew the answer to that question, because for whatever reason [Center for Medicare and Medicaid Innovation] has guarded the results of the [Oncology Care Model] like they’re a state secret, which is absolutely nuts if you ask me. I think we learn most when we have benchmarking and we can examine our own processes of care. A couple of things I think we have learned hospitalization for toxicity management should be never events. People should be managed in the outpatient setting whenever it’s at all feasible. I think we’ve seen a lot of standardization of that care.
Second, we’ve seen a wide-scale adoption embracing of the patient navigator as an important component of the care team. I think if you don’t have a navigator, you’re nuts and you need to implement a navigation function; it makes everything else work better down the line.
The third thing is, and this hasn’t been done quite as much, is that practices who have really started to focus on physician prescribing behavior and opportunities for tweaking that are going to do well. We know, for example, there are practices that went immediately to biosimilars; they’ve done really, really well. We have heard of practices that are signing up for pathways programs because they think they’re important.
I would say those 3 things are really important. The fourth one that we haven’t really seen yet, but I think we will see, are broad adoption of end-of-life programs, palliative care and end of life, because that’s an unmet need and there are solutions now that are out there.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More